Named on 5 rounds in the feed, most often at Series B and in Biotech.
Rounds from 2024-07-14 to 2026-08-27
ROUNDS
5
joined, none as lead
ROUNDS JOINED · USD
$343M
across 5 rounds
CO-INVESTORS
7
named beside it
Named on 5 rounds in the feed, most often at Series B and in Biotech.
Rounds from 2024-07-14 to 2026-08-27
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
AusperBio Therapeutics, Inc. A startup developing therapeutics for chronic hepatitis B and other diseases | Series C Verified against 4 of 8 sources | $120M | 2026-08-27 | [ PART ] |
AusperBio Therapeutics, Inc. A startup developing therapeutics for chronic hepatitis B and other diseases | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $63M | 2025-09-22 | [ PART ] |
AusperBio Therapeutics, Inc. A startup developing therapeutics for chronic hepatitis B and other diseases | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2025-05-28 | [ PART ] |
AusperBio Therapeutics, Inc. A startup developing therapeutics for chronic hepatitis B and other diseases | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $73M | 2024-12-26 | [ PART ] |
AusperBio Therapeutics, Inc. A startup developing therapeutics for chronic hepatitis B and other diseases | Series A Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $37M | 2024-07-14 | [ PART ] |